参考文献/References:
[1]Lam A,Prabhu R,Gross C M,et al.Role of apoptosis and autophagy in tuberculosis[J].American Journal of Physiology-Lung Cellular and Molecular Physiology,2017,313(2):L218-L229.[2]Ehrt S,Schnappinger D,Rhee KY.Metabolic principles of persistence and pathogenicity in Mycobacterium tuberculosis[J].Nat Rev Microbiol,2018,16(8):496-507[3]Chakaya J,Khan M,Ntoumi F,et al.Global Tuberculosis Report 2020- Reflections on the Global TB burden, treatment and prevention efforts[J].Int J Infect Dis,2021,113(Suppl 1):S7-S12.[4]Khare G,Nangpal P,Tyagi AK.Differential Roles of Iron Storage Proteins in Maintaining the Iron Homeostasis in Mycobacterium tuberculosis[J].PLoS One,2017,12(1):e169545.[5]李琳雪.结核分枝杆菌Rv1860、Rv0494及Rv1876蛋白在活动性结核病诊断中的临床应用研究[D].遵义:遵义医科大学,2020.[6]Singh R,Dwivedi SP,Gaharwar US,et al.Recent updates on drug resistance inMycobacterium tuberculosis[J].Journal of Applied Microbiology,2020,128(6):1547-1567.[7]Peters JS,Andrews JR,Hatherill M,et al.Advances in the understanding of Mycobacterium tuberculosis transmission in HIV-endemic settings[J].The Lancet Infectious Diseases,2019,19(3):e65-e76.[8]Mustafa AD,Kalyanasundram J,Sabidi S,et al.Proof of concept in utilizing in-trans surface display system of Lactobacillus plantarum as mucosal tuberculosis vaccine via oral administration in mice[J].BMC Biotechnology,2018,18(1):63.[9]Ranjbar MM,Ebrahimi MM,Shahsavandi S,et al.Novel Applications of Immuno-bioinformatics in Vaccine and Bio-product Developments at Research Institutes[J].Arch Razi Inst,2019,74(3):219-233.[10]Kozakiewicz L,Phuah J,Flynn J,et al.The role of B cells and humoral immunity in Mycobacterium tuberculosis infection[J].Adv Exp Med Biol,2013(783):225-250.[11]Kawahara JY,Irvine EB,Alter G.A Case for Antibodies as Mechanistic Correlates of Immunity in Tuberculosis[J].Frontiers in Immunology,2019(10):996[12]Jurewicz MM,Stern LJ.Class Ⅱ MHC antigen processing in immune tolerance and inflammation[J].Immunogenetics,2019,71(3):171-187.[13]Jasenosky LD,Scriba TJ,Hanekom WA,et al.T cells and adaptive immunity toMycobacterium tuberculosis in humans[J].Immunological Reviews,2015,264(1):74-87.[14]Orlando V,La Manna MP,Goletti D,et al.Human CD4 T-Cells With a Naive Phenotype Produce Multiple Cytokines During Mycobacterium Tuberculosis Infection and Correlate With Active Disease[J].Front Immunol,2018(9):1119.[15]Yuan C,Qu ZL,Tang XL,et al.Mycobacterium tuberculosis Mannose-Capped Lipoarabinomannan Induces IL-10-Producing B Cells and Hinders CD4+ Th1 Immunity[J].iScience,2019(11):13-30.[16]Farsida,Shabariah R,Hatta M,et al.Relationship between expression mRNA gene Treg, Treg, CD4+, and CD8+ protein levels with TST in tuberculosis children: A nested case-control[J].Ann Med Surg (Lond),2020(61):44-47.[17]Bohme J,Martinez N,Li S,et al.Metformin enhances anti-mycobacterial responses by educating CD8+ T-cell immunometabolic circuits[J].Nat Commun,2020,11(1):5225.[18]Yang JD,Mott D,Sutiwisesak R,et al.Mycobacterium tuberculosis-specific CD4+ and CD8+ T cells differ in their capacity to recognize infected macrophages[J].PLoS Pathog,2018,14(5):e1007060.[19]Pomaznoy M,Kuan R,Lindvall M,et al.Quantitative and Qualitative Perturbations of CD8+ MAITs in Healthy Mycobacterium tuberculosis-Infected Individuals[J].Immunohorizons,2020,4(6):292-307.[20]Rai PK,Chodisetti SB,Maurya SK,et al.A lipidated bi-epitope vaccine comprising of MHC-Ⅰ and MHC-Ⅱ binder peptides elicits protective CD4 T cell and CD8 T cell immunity against Mycobacterium tuberculosis[J].J Transl Med,2018,16(1):279.[21]Zaitouna AJ,Kaur A,Raghavan M.Variations in MHC class Ⅰ antigen presentation and immunopeptidome selection pathways[J].F1000Research,2020(9):1177.[22]Lin PL,Flynn JL.CD8 T cells and Mycobacterium tuberculosis infection[J].Seminars in Immunopathology,2015,37(3):239-249.[23]Chavez-Galan L,Illescas-Eugenio J,Alvarez-Sekely M,et al.Tuberculosis patients display a high proportion of CD8(+) T cells with a high cytotoxic potential[J].Microbiol Immunol,2019,63(8):316-327.[24]Green AM,Difazio R,Flynn JL.IFN-γ from CD4 T cells is essential for host survival and enhances CD8 T cell function during Mycobacterium tuberculosis infection[J].J Immunol,2013,190(1):270-277.[25]Hao X,Bai J,Ding Y,et al.Characterization of antibody response against 16kD and 38kD of M.tuberculosis in the assisted diagnosis of active pulmonary tuberculosis[J].Annals of Translational Medicine,2020,8(15):945.[26]Ma Y,Li R,Shen J,et al.Clinical effect of T-SPOT.TB test for the diagnosis of tuberculosis[J].BMC Infectious Diseases,2019,19(1):993.[27]Sable SB,Posey JE,Scriba TJ.Tuberculosis Vaccine Development: Progress in Clinical Evaluation[J].Clinical Microbiology Reviews,2019,33(1):e00100-19.
相似文献/References:
[1]刘德福.肺结核患者痰中结核分枝杆菌检验的临床价值分析[J].医学信息,2018,31(01):151.[doi:10.3969/j.issn.1006-1959.2018.01.059]
LIU De-fu.Clinical Value Analysis of Mycobacterium tuberculosis in Sputum of Patients with
Pulmonary Tuberculosis[J].Medical Information,2018,31(06):151.[doi:10.3969/j.issn.1006-1959.2018.01.059]
[2]陈 波,马晓波,洪国粦.Xpert MTB/RIF技术对结核分枝杆菌的诊断价值[J].医学信息,2019,32(06):172.[doi:10.3969/j.issn.1006-1959.2019.06.056]
CHEN Bo,MA Xiao-bo,HONG Guo-lin.Diagnostic Value of Xpert MTB/RIF Technique for Mycobacterium Tuberculosis[J].Medical Information,2019,32(06):172.[doi:10.3969/j.issn.1006-1959.2019.06.056]
[3]胡立珍,周广信,霍丽丽,等.全自动半巢式实时荧光定量PCR技术检测
BALF诊断肺结核的价值[J].医学信息,2019,32(15):165.[doi:10.3969/j.issn.1006-1959.2019.15.056]
HU Li-zhen,ZHOU Guang-xin,HUO Li-li,et al.Detection of the Value of BALF in the Diagnosis of Pulmonary Tuberculosis by
Automatic Semi-nested Real-time PCR[J].Medical Information,2019,32(06):165.[doi:10.3969/j.issn.1006-1959.2019.15.056]
[4]李 鑫.肺结核合并气管支气管结核危险因素及诊断[J].医学信息,2020,33(01):32.[doi:10.3969/j.issn.1006-1959.2020.01.012]
LI Xin.Risk Factors and Diagnosis of Tuberculosis with Tracheobronchial Tuberculosis[J].Medical Information,2020,33(06):32.[doi:10.3969/j.issn.1006-1959.2020.01.012]
[5]徐 玥,王 璞.吸烟对肺结核发病、临床特征及转归的影响[J].医学信息,2021,34(05):54.[doi:10.3969/j.issn.1006-1959.2021.05.016]
XU Yue,WANG Pu.The Effect of Smoking on the Incidence,Clinical Characteristics and Outcome of Tuberculosis[J].Medical Information,2021,34(06):54.[doi:10.3969/j.issn.1006-1959.2021.05.016]
[6]黄 丹,王 璞.肉芽肿性肺疾病的研究现状[J].医学信息,2022,35(05):44.[doi:10.3969/j.issn.1006-1959.2022.05.011]
HUANG Dan,WANG Pu.Research Status of Granulomatous Lung Disease[J].Medical Information,2022,35(06):44.[doi:10.3969/j.issn.1006-1959.2022.05.011]
[7]曾冬梅.血清中结核分枝杆菌IgG、IgM抗体检测在肺结核诊断中的应用价值[J].医学信息,2022,35(22):157.[doi:10.3969/j.issn.1006-1959.2022.22.039]
ZENG Dong-mei.The Application Value of Serum Mycobacterium Tuberculosis IgG and IgM Antibody Detection in the Diagnosis of Pulmonary Tuberculosis[J].Medical Information,2022,35(06):157.[doi:10.3969/j.issn.1006-1959.2022.22.039]
[8]杨晓悦,李毓龙,罗仲秋,等.结合分枝杆菌感染者辅助性Th2型细胞因子IL-4、IL-6、IL-10的水平变化[J].医学信息,2023,36(01):113.[doi:10.3969/j.issn.1006-1959.2023.01.022]
YANG Xiao-yue,LI Yu-long,LUO Zhong-qiu,et al.Changes of Helper Th2 Cytokines IL-4, IL-6 and IL-10 Levels in Patients with Mycobacterium Tuberculosis Infection[J].Medical Information,2023,36(06):113.[doi:10.3969/j.issn.1006-1959.2023.01.022]
[9]于 江,孙 杰,刘凤君.结核分枝杆菌抗原在结核病病理学诊断中的研究进展[J].医学信息,2023,36(08):170.[doi:10.3969/j.issn.1006-1959.2023.08.038]
YU Jiang,SUN Jie,LIU Feng-jun.Research Progress of Mycobacterium Tuberculosis Antigen in Pathological Diagnosis of Tuberculosis[J].Medical Information,2023,36(06):170.[doi:10.3969/j.issn.1006-1959.2023.08.038]
[10]高 灿,赵晓彤,程 江.结核分枝杆菌TB10.4蛋白的生物信息学分析[J].医学信息,2023,36(18):1.[doi:10.3969/j.issn.1006-1959.2023.18.001]
GAO Can,ZHAO Xiao-tong,CHENG Jiang.Bioinformatics Analysis of Mycobacterium Tuberculosis TB10.4 Protein[J].Medical Information,2023,36(06):1.[doi:10.3969/j.issn.1006-1959.2023.18.001]